Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt
about
The tell-tale heart: molecular and cellular responses to childhood anthracycline exposureCardiac endothelium-myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fractionNeuregulin as a heart failure therapy and mediator of reverse remodelingNeuregulin-1β induces embryonic stem cell cardiomyogenesis via ErbB3/ErbB2 receptors.Potential Therapeutic Strategies for Hypertension-Exacerbated Cardiotoxicity of Anticancer DrugsThe Role of Exercise in Cardiac Aging: From Physiology to Molecular MechanismsHeme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagyThe neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity.Activation of the neuregulin/ErbB system during physiological ventricular remodeling in pregnancy.Cancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies.Mechanisms of anthracycline cardiotoxicity and strategies to decrease cardiac damage.Actin binding GFP allows 4D in vivo imaging of myofilament dynamics in the zebrafish heart and the identification of Erbb2 signaling as a remodeling factor of myofibril architecture.Serum Neuregulin-1beta as a Biomarker of Cardiovascular Fitness.The Role of Supportive Therapy in the Era of Modern Adjuvant Treatment - Current and Future Tools.Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection?Activation of EGFR/ERBB2 via pathways involving ERK1/2, P38 MAPK, AKT and FOXO enhances recovery of diabetic hearts from ischemia-reperfusion injuryA Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth.ErbB signaling in cardiac development and disease.Recombinant neuregulin 1 does not activate cardiomyocyte DNA synthesis in normal or infarcted adult mice.Neuregulin-1β regulation of embryonic endothelial progenitor cell survival.Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons.Neuregulin-1β induces mature ventricular cardiac differentiation from induced pluripotent stem cells contributing to cardiac tissue repair.Physiological, pharmacological and toxicological considerations of drug-induced structural cardiac injuryImproving murine embryonic stem cell differentiation into cardiomyocytes with neuregulin-1: differential expression of microRNA.Platelet endothelial cell adhesion molecule-1 mediates endothelial-cardiomyocyte communication and regulates cardiac function.Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.Neuregulin-1β for the treatment of systolic heart failure.Transgenic zebrafish model to study translational control mediated by upstream open reading frame of human chop gene.Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway.Neuregulin/ErbB regulate neuromuscular junction development by phosphorylation of α-dystrobrevinApoptosis in Anthracycline CardiomyopathyErbB4 localization to cardiac myocyte nuclei, and its role in myocyte DNA damage response.A novel non-canonical mechanism of regulation of MST3 (mammalian Sterile20-related kinase 3).Neuregulin protects human umbilical vein endothelial cell via activating CD98hc through MAPK pathway.The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferationImprovement of cardiac function and reversal of gap junction remodeling by Neuregulin-1β in volume-overloaded rats with heart failure.Molecular Characterization of Striated Muscle-Specific Gab1 Isoform as a Critical Signal Transducer for Neuregulin-1/ErbB Signaling in Cardiomyocytes.Activation of NRG1-ERBB4 signaling potentiates mesenchymal stem cell-mediated myocardial repairs following myocardial infarction.Endothelial-cardiomyocyte interactions in cardiac development and repairMyocardial Mycn is essential for mouse ventricular wall morphogenesis.
P2860
Q26823592-446D987E-5F11-4837-9733-69244D417883Q26853363-101FDB26-94F7-4748-986F-A261F8C8D606Q26991903-A16EDB19-9FF7-48B5-8950-993B3BF68255Q27334101-C066132B-DE04-4723-B495-9F4132DAE3EEQ28070311-302446FE-FFA6-44D2-B8C2-335DDE2006D0Q28397317-2A04D442-41CB-4BC5-BB30-6B3FAC276F89Q28533775-926A37D4-1CAA-4736-A553-F0816F1239E7Q28568657-1A37A85C-2AD0-4540-BC4D-0C6F982B8D45Q29347286-EA74AD91-3A7F-4EE9-98F7-E0129496D27EQ30426853-BBA59B27-44C4-4C4D-B435-2E331A3A470FQ30439608-E0FB1805-A721-4A9F-8405-E7DE61868EA1Q30631200-B0CF92E0-5214-42D1-B636-9F05CB516991Q33993588-3AC10D9B-1E8E-460A-9505-2074ED59FC69Q34095827-C847B000-49A0-425D-97FC-701C32D029F4Q34102834-9633D737-A9E6-437F-8224-A599F85873CFQ34312113-886354F2-798A-4450-AEA2-7CE775E5D523Q34361366-443E8984-D91B-4591-B2A2-F181F20A0065Q34545577-E7C8DA28-EFDD-48E9-80BD-CDF1D79154E1Q34784347-1C3039B3-419D-47A2-8B96-21B53CF51E80Q34784406-D34855A4-ED76-4472-8EB1-A1D2D977EBFAQ34806634-25BC5D82-6924-4151-A1DD-F6A0ECBB4877Q35036634-B706B039-419F-48EA-87FA-45C1E5F0CF44Q35039202-F0FBC4B2-77F3-46C5-8369-ACA20D0FB313Q35086774-DD5A45DC-554D-45CB-824E-2D54490CBD3FQ35088053-BBDFFFCA-2127-46EF-9C3D-ED86A56A16FEQ35207833-354DD9C0-ECD0-4C66-8C1D-117BB3891F6AQ35231868-BCB828D4-EC76-416A-8B24-018823A88614Q35468153-C01E5248-7D86-4FE7-9358-511B37A4E446Q35568967-3DC5F8B0-E115-45B6-B50F-6FB708827074Q35636593-814F7D60-F9C2-4D06-AF22-E553E9112CEEQ35642302-4A64E216-9616-48A0-83C1-C2E0F4501F65Q35740039-F12D6DA9-AE43-47D5-B3A7-31EBC61598E4Q35778782-5D940AE4-8174-40C0-8FA3-CC67A555A1BEQ35870563-BAD698D9-17D0-4826-B39D-00A8C326BFD8Q36042588-35E756F6-7B2C-437A-AAAD-0B276FF44D94Q36163718-B05C9A34-C3B4-412E-BD87-D95E173B3336Q36197691-F6532DB5-15F6-46D5-89AC-74BC86A06B9DQ36346991-5901B6A7-E1B1-4E97-BE3E-2CB58ABE98A1Q36387870-D47BF10B-AF70-4977-845F-D7A72944AB38Q36428295-922D6D29-5CB3-43F0-BD23-F4BEB2ADA68E
P2860
Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt
description
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Dezember 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/12/01)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/12/01)
@nl
наукова стаття, опублікована в грудні 2003
@uk
مقالة علمية (نشرت في ديسمبر 2003)
@ar
name
Neuregulin-1 protects ventricu ...... t activation of PI3-kinase/Akt
@ast
Neuregulin-1 protects ventricu ...... t activation of PI3-kinase/Akt
@en
Neuregulin-1 protects ventricu ...... t activation of PI3-kinase/Akt
@nl
type
label
Neuregulin-1 protects ventricu ...... t activation of PI3-kinase/Akt
@ast
Neuregulin-1 protects ventricu ...... t activation of PI3-kinase/Akt
@en
Neuregulin-1 protects ventricu ...... t activation of PI3-kinase/Akt
@nl
prefLabel
Neuregulin-1 protects ventricu ...... t activation of PI3-kinase/Akt
@ast
Neuregulin-1 protects ventricu ...... t activation of PI3-kinase/Akt
@en
Neuregulin-1 protects ventricu ...... t activation of PI3-kinase/Akt
@nl
P2093
P3181
P1476
Neuregulin-1 protects ventricu ...... t activation of PI3-kinase/Akt
@en
P2093
Douglas B. Sawyer
Mark A. Marchionni
Ralph A. Kelly
Ryuji Fukazawa
Stefan Frantz
Thomas A. Miller
Young Dae Kim
Yukio Kuramochi
P304
P3181
P356
10.1016/J.YJMCC.2003.09.012
P577
2003-12-01T00:00:00Z